Product Images Emrelis
View Photos of Packaging, Labels & Appearance
- Telisotuzumab vedotin-tllv is a c-Met directed antibody-drug conjugate (ADC) comprised of a humanized immunoglobulin G1 kappa (IgG1κ) monoclonal antibody conjugated to the small molecule microtubule-disrupting agent, monomethyl auristatin E (MMAE), via a protease-cleavable valine-citrulline (vc) linker. The antibody is produced in a mammalian cell line (Chinese hamster ovary) and the drug-linker is produced by chemical synthesis. Each monoclonal antibody molecule carries an average of 3 MMAE molecules. Telisotuzumab vedotin-tllv has an approximate molecular weight of 152 kDa. - emrelis teliso v 01
- PRINCIPAL DISPLAY PANELNDC 0074-1044-01Emrelis™(telisotuzumab vedotin-tllv)For Injection20 mg per vialHazardous DrugFor Intravenous Infusion after reconstitutionand dilutionSingle-Dose VialDiscard Unused PortionDispense the enclosed Medication Guide to each patientRx Onlyabbvie - emrelis teliso v 02
- PRINCIPAL DISPLAY PANELNDC 0074-1055-01Emrelis™(telisotuzumab vedotin-tllv)For Injection100 mg per vialHazardous DrugFor Intravenous Infusion after reconstitutionand dilutionSingle-Dose VialDiscard Unused PortionDispense the enclosed Medication Guide to each patientRx Onlyabbvie - emrelis teliso v 03
Product Label Images
The following 3 images provide visual information about the product associated with Emrelis NDC 0074-1044 by Abbvie Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Telisotuzumab vedotin-tllv is a c-Met directed antibody-drug conjugate (ADC) comprised of a humanized immunoglobulin G1 kappa (IgG1κ) monoclonal antibody conjugated to the small molecule microtubule-disrupting agent, monomethyl auristatin E (MMAE), via a protease-cleavable valine-citrulline (vc) linker. The antibody is produced in a mammalian cell line (Chinese hamster ovary) and the drug-linker is produced by chemical synthesis. Each monoclonal antibody molecule carries an average of 3 MMAE molecules. Telisotuzumab vedotin-tllv has an approximate molecular weight of 152 kDa. - emrelis teliso v 01
PRINCIPAL DISPLAY PANELNDC 0074-1044-01Emrelis™(telisotuzumab vedotin-tllv)For Injection20 mg per vialHazardous DrugFor Intravenous Infusion after reconstitutionand dilutionSingle-Dose VialDiscard Unused PortionDispense the enclosed Medication Guide to each patientRx Onlyabbvie - emrelis teliso v 02
PRINCIPAL DISPLAY PANELNDC 0074-1055-01Emrelis™(telisotuzumab vedotin-tllv)For Injection100 mg per vialHazardous DrugFor Intravenous Infusion after reconstitutionand dilutionSingle-Dose VialDiscard Unused PortionDispense the enclosed Medication Guide to each patientRx Onlyabbvie - emrelis teliso v 03
